A nationwide evaluation of pancreatic cancer treatment

E. Pijnappel

A nationwide evaluation of pancreatic cancer treatment

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

The objective of the studies in this thesis is to improve the outcome of patients with pancreatic cancer and describe the use and overall survival (OS) of first and second-line systemic treatment for patients with advanced disease. In addition, factors that should be reported in future randomized controlled trials (RCTs) for patients with resectable disease are identified, facilitating better comparison between studies. Furthermore, quality of life and patient characteristics that may influence treatment allocation and outcome are evaluated.

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution
Supervisors/Advisors	Wilmink, Johanna W., Supervisor van Laarhoven, Hanneke, Supervisor Besselink, Marc, Co-supervisor
Award date	24 Jun 2022
Print ISBNs	9789464237887
Publication status	Published - 2022

Access to Document

Cite this

@phdthesis{157bf15f80e34dceae25405a10de72e2,

title = "A nationwide evaluation of pancreatic cancer treatment",

abstract = "The objective of the studies in this thesis is to improve the outcome of patients with pancreatic cancer and describe the use and overall survival (OS) of first and second-line systemic treatment for patients with advanced disease. In addition, factors that should be reported in future randomized controlled trials (RCTs) for patients with resectable disease are identified, facilitating better comparison between studies. Furthermore, quality of life and patient characteristics that may influence treatment allocation and outcome are evaluated.",

author = "E. Pijnappel",

year = "2022",

language = "English",

isbn = "9789464237887",

type = "Phd-Thesis - Research and graduation internal",

}

TY - THES

T1 - A nationwide evaluation of pancreatic cancer treatment

AU - Pijnappel, E.

PY - 2022

Y1 - 2022

N2 - The objective of the studies in this thesis is to improve the outcome of patients with pancreatic cancer and describe the use and overall survival (OS) of first and second-line systemic treatment for patients with advanced disease. In addition, factors that should be reported in future randomized controlled trials (RCTs) for patients with resectable disease are identified, facilitating better comparison between studies. Furthermore, quality of life and patient characteristics that may influence treatment allocation and outcome are evaluated.

AB - The objective of the studies in this thesis is to improve the outcome of patients with pancreatic cancer and describe the use and overall survival (OS) of first and second-line systemic treatment for patients with advanced disease. In addition, factors that should be reported in future randomized controlled trials (RCTs) for patients with resectable disease are identified, facilitating better comparison between studies. Furthermore, quality of life and patient characteristics that may influence treatment allocation and outcome are evaluated.

UR - https://pure.uva.nl/ws/files/73292924/Licentieovereenkomst_medeondertekend_.pdf

M3 - Phd-Thesis - Research and graduation internal

SN - 9789464237887

ER -

A nationwide evaluation of pancreatic cancer treatment

Abstract

Access to Document

Other files and links

Cite this